CalciMedica
CALC
22 hedge funds and large institutions have $187M invested in CalciMedica in 2020 Q3 according to their latest regulatory filings, with 22 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| 1 |
DM
Deerfield Management
New York
|
+$78.7M |
| 2 |
O
OrbiMed
New York
|
+$66.7M |
| 3 |
Blackstone Inc
New York
|
+$28.7M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$23.5M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$5.81M |
Top Sellers
CALC Hedge Fund Activity: Q3 2020 in Review
22 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in CalciMedica (CALC) for Q3 2020, worth a combined $187M.
Buyers outnumbered sellers: 22 funds opened new CALC positions and 0 closed out — a net gain of 22 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Deerfield Management, opening a new position worth an estimated $78.7M.
- 22 institutional investors held CalciMedica (CALC) as of Q3 2020, up from 0 in Q2 2020.
- Funds reported $187M of CalciMedica stock for Q3 2020.
- 22 funds opened new CalciMedica positions in Q3 2020 and 0 closed out, a net change of +22 holders.
- The largest CalciMedica buyer in Q3 2020 was Deerfield Management, an estimated $78.7M added.
Based on aggregated 13F filings for Q3 2020.